accelerated-approval
Every record this desk has filed under accelerated-approval, newest first, each with the number of sources it can still show you.
FDA grants accelerated approval to an immunotherapy for adults with recurrent respiratory papillomatosis, with benefit still to be confirmed
The FDA granted accelerated approval October 30 to Voceryq for adults with recurrent respiratory papillomatosis, a rare airway disease that can require repeated surgery. The agency cited fewer surgical procedures in a small, open-label trial. The manufacturer must run post-approval trials to verify the clinical benefit; the approval announcement does not establish that the treatment cures the disease.
Also filed underfdarespiratory-diseaseclinical-trialspatient-care
A record appears here because it carries accelerated-approval in its own tags. If a record you expected is missing, it was filed under a different subject — the full list is on the topics index.